SCHEMBL7638570

SCHEMBL7638570

C=CCC=C(CC=C)CC=C

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6677297 0.86 TSHR (0.33) TSHR
SCHEMBL6677303 0.75 TSHR (0.47) TSHR
SCHEMBL8673159 0.75 TSHR (0.32) TSHR
SCHEMBL8767073 0.73
SCHEMBL8767075 0.73
SCHEMBL7676124 0.73 ALDH1A1 (0.35) TSHR
SCHEMBL7196179 0.73 TSHR (0.30) TSHR
SCHEMBL846615 0.73
SCHEMBL278195 0.73 ALDH1A1 (0.44) TSHR
SCHEMBL9879515 0.73 TSHR (0.32) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3966187-A1 PROMOTERS FOR HETEROGENEOUS OLEFIN METATHESIS Massachusetts Institute of Technology (US) 2022-03-16 EP claimed
WO-2020227616-A1 PROMOTERS FOR HETEROGENEOUS OLEFIN METATHESIS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2020-11-12 WO claimed
US-20200354291-A1 PROMOTERS FOR HETEROGENEOUS OLEFIN METATHESIS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2020-11-12 US claimed
CN-114981319-A Polyvinyl alcohol resin, method for producing polyvinyl alcohol resin, dispersant, and dispersant for suspension polymerization 三菱化学株式会社 2022-08-30 CN disclosed
EP-3966187-A1 PROMOTERS FOR HETEROGENEOUS OLEFIN METATHESIS Massachusetts Institute of Technology (US) 2022-03-16 EP disclosed
CN-113544163-A Polyvinyl alcohol resin, method for producing polyvinyl alcohol resin, dispersant, and dispersant for suspension polymerization 三菱化学株式会社 2021-10-22 CN disclosed
US-20200354291-A1 PROMOTERS FOR HETEROGENEOUS OLEFIN METATHESIS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2020-11-12 US disclosed
WO-2020227616-A1 PROMOTERS FOR HETEROGENEOUS OLEFIN METATHESIS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2020-11-12 WO disclosed
US-20020019429-A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use BENDER STEVEN L (US) 2002-02-14 US disclosed
US-6306892-B1 ENZYME INHIBITORS HETEROCYCLIC AMIDES AGOURON PHARMACEUTICALS, INC. 2001-10-23 US disclosed
US-6174915-B1 FOR TREATING MAMMALIAN DISEASE CONDITION MEDIATED BY METALLOPROTEINASE ACTIVITY AGOURON PHARMACEUTICALS, INC. 2001-01-16 US disclosed
US-4705847-A Polycycloalkylidene-polycycloalkanes, epidioxy derivatives thereof and method of preparation AKZO N.V. (NL) 1987-11-10 US disclosed
EP-0106863-B1 A PROCESS FOR PREPARING SUBSTITUTED POLYCYCLO-ALKYLIDENE POLYCYCLO-ALKANES AS WELL AS SAID SUBSTITUTED POLYCYCLO-ALKYLIDENE POLYCYCLO-ALKANES RIJKSUNIVERSITEIT TE GRONINGEN (NL) 1986-08-20 EP disclosed
US-4511753-A Selective removal of vinylidene olefin from olefin mixtures ETHYL CORPORATION (US) 1985-04-16 US disclosed
EP-0106863-A1 A PROCESS FOR PREPARING SUBSTITUTED POLYCYCLO-ALKYLIDENE POLYCYCLO-ALKANES AS WELL AS SAID SUBSTITUTED POLYCYCLO-ALKYLIDENE POLYCYCLO-ALKANES. UNIV GRONINGEN (NL) 1984-05-02 EP disclosed
WO-1983003604-A1 A PROCESS FOR PREPARING SUBSTITUTED POLYCYCLO-ALKYLIDENE POLYCYCLO-ALKANES AND THE CORRESPONDING EPIDIOXY COMPOUNDS; AS WELL AS SAID SUBSTITUTED POLYCYCLO-ALKYLIDENE POLYCYCLO-ALKANES AND THE CORRESPONDING EPIDIOXY COMPOUNDS HUMMELEN, JAN, CORNELIS 1983-10-27 WO disclosed
EP-0081509-A4 VINYL GUM CURE ACCELERATORS FOR ADDITION-CURE SILICONE. GEN ELECTRIC (US) 1983-07-26 EP disclosed
EP-0081509-A1 VINYL GUM CURE ACCELERATORS FOR ADDITION-CURE SILICONE. GEN ELECTRIC (US) 1983-06-22 EP disclosed
WO-1982004013-A1 VINYL GUM CURE ACCELERATORS FOR ADDITION-CURE SILICONE GEN ELECTRIC (US) 1982-11-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020019429-A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use MMP9, MMP2, MMP3 TSHR 3670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.